These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11914471)

  • 1. Classic and recent special stains used in differential diagnosis of endocrine tumors.
    Bussolati G; Volante M; Papotti M
    Endocr Pathol; 2001; 12(4):379-87. PubMed ID: 11914471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine needle aspiration cytology of endocrine neoplasms of the pancreas. Morphologic and immunocytochemical findings in 20 cases.
    Jiménez-Heffernan JA; Vicandi B; López-Ferrer P; González-Peramato P; Pérez-Campos A; Viguer JM
    Acta Cytol; 2004; 48(3):295-301. PubMed ID: 15192942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.
    Rosa P; Gerdes HH
    J Endocrinol Invest; 1994 Mar; 17(3):207-25. PubMed ID: 8051343
    [No Abstract]   [Full Text] [Related]  

  • 4. [An immunohistochemical study and its clinical application for endocrine disorders using monoclonal antibodies].
    Shimizu K; Eisenbarth GS; Shoji T
    Nihon Ika Daigaku Zasshi; 1991 Dec; 58(6):615-20. PubMed ID: 1770115
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene expression profiling of endocrine tumors using DNA microarrays: progress and promise.
    Giordano TJ
    Endocr Pathol; 2003; 14(2):107-16. PubMed ID: 12858000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endocrine tumor].
    Sasano H
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):121-4. PubMed ID: 15675597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of the HER-2/neu protooncogene in human endocrine tumors.
    Evers BM; Rády PL; Tyring SK; Sanchez RL; Rajaraman S; Townsend CM; Thompson JC
    Surgery; 1992 Aug; 112(2):211-7; discussion 217-8. PubMed ID: 1353638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry in the differential diagnosis of acinar and endocrine pancreatic neoplasms.
    Skacel M; Ormsby AH; Petras RE; McMahon JT; Henricks WH
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):203-9. PubMed ID: 10981872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIP/PAP, a member of the reg family, is expressed in glucagon-producing enteropancreatic endocrine cells and tumors.
    Hervieu V; Christa L; Gouysse G; Bouvier R; Chayvialle JA; Bréchot C; Scoazec JY
    Hum Pathol; 2006 Aug; 37(8):1066-75. PubMed ID: 16867870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors.
    Schmitt AM; Schmid S; Rudolph T; Anlauf M; Prinz C; Klöppel G; Moch H; Heitz PU; Komminoth P; Perren A
    Endocr Relat Cancer; 2009 Dec; 16(4):1219-27. PubMed ID: 19690016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA factors in endocrine neoplasia.
    Pihlajoki M; Färkkilä A; Soini T; Heikinheimo M; Wilson DB
    Mol Cell Endocrinol; 2016 Feb; 421():2-17. PubMed ID: 26027919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indication and performance of endocrine surgery. The significance of molecular genetic examination].
    Goretzki PE; Wirowski D; Schwarz K; Pohl P; Böhner H; Starke A; Lammers BJ
    Chirurg; 2009 Feb; 80(2):122-9. PubMed ID: 19096808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for malignancy in gastrointestinal endocrine tumors.
    Bordi C; D'Adda T; Azzoni C; Pizzi S; Bottarelli L; Mormandi F; Antonetti T; Luong TV; Rindi G
    Endocr Pathol; 2006; 17(2):119-29. PubMed ID: 17159244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.
    La Rosa S; Rigoli E; Uccella S; Chiaravalli AM; Capella C
    Virchows Arch; 2004 Sep; 445(3):248-54. PubMed ID: 15517368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of myosin XVA in endocrine tumors of gut and pancreas.
    La Rosa S; Capella C; Lloyd RV
    Endocr Pathol; 2002; 13(1):29-37. PubMed ID: 12114748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of immunohistochemistry in lesions of the endocrine system].
    Sporny S; Taran K
    Endokrynol Pol; 2005; 56(3):346-54. PubMed ID: 16350730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology insight: microarrays--research and clinical applications.
    Vlacich G; Roe C; Webb GC
    Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):594-605. PubMed ID: 17643130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochemical Staining.
    Paessler ME; Helfrich M; Wertheim GBW
    Methods Mol Biol; 2017; 1633():19-32. PubMed ID: 28735478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of gastrin mRNA in human antral mucosa and digestive endocrine tumors by in situ hybridization: a correlative study with immunocytochemistry and electron microscopy.
    Walker FM; Lehy T; Bernuau DG; Sobhani I; Bayle D; Feldmann G; Lewin MJ
    J Histochem Cytochem; 1992 Sep; 40(9):1363-72. PubMed ID: 1506673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gs alpha--identification of a gene highly expressed by insulinoma and other endocrine tumors.
    Zeiger MA; Norton JA
    Surgery; 1993 Aug; 114(2):458-62; discussion 462-3. PubMed ID: 8342148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.